Alphabet unit CapitalG returned for an Accel-led series D round that included Telstra, and which took the endpoint security software provider’s valuation above $1bn.
Month: May 2017
G1 gets a listing in $105m IPO
Cancer therapy developer G1 Therapeutics has gone public in an initial public offering that gave an exit to long-time investor MedImmune Ventures.
AdRise soars with $21m
AdRise, the US-based, corporate-backed operator of online streaming platform Tubi TV, has raised $21m in funding from an undisclosed investor, NewsCenter.io has reported. A regulatory filing made last week reveals AdRise is seeking a final close of $24.2m for the round. Tubi TV is an online movie streaming platform that relies on monetisation through advertising… Continue reading AdRise soars with $21m
Synlogic makes sense of Mirna merger
The reverse merger with Nasdaq-listed Mirna, which counts Pfizer and Baxter as backers, was agreed alongside the disclosure of a $42m series C round.
SocialTools gets picked up as Wayra exits
Wayra, the accelerator subsidiary of telecommunications company Telefónica, has exited Argentina-based social media management platform developer SocialTools through an acquisition by an unnamed US-based investment fund, La Voz has reported. Founded in 2012, SocialTools has built a software platform that enables businesses to manage their marketing on social media. Wayra had taken a 10% stake… Continue reading SocialTools gets picked up as Wayra exits
Knapp authors his GV ending
Jake Knapp, the GV design partner that developed the Design Sprint process, has left the unit after five years to become a full-time writer.
BiomX cycles to $24m series A
Israel-based microbiome therapy developer BiomX raised $24m on Monday in a series A round co-led by healthcare investment firm OrbiMed and subsidiaries of pharmaceutical firms Johnson & Johnson and Takeda. The round also featured Seventure Partners, MiraeAsset and SBI Japan-Israel Innovation Fund, the latter backed by financial services provider SBI Group. The pharmaceutical companies invested… Continue reading BiomX cycles to $24m series A
Lakshachandi moves into $20m White Unicorn fund
Property developer Lakshachandi Realty and an affiliated company have provided $10m for Indian venture firm White Unicorn Ventures’s maiden fund.
Google’s pursuit of Owlchemy ends in acquisition
HTC, Qualcomm and Colopl have exited virtual reality game developer Owlchemy in an acquisition of undisclosed size by Google.
Eve Sleep rests easy after $45m IPO
UK-based mattress producer Eve Sleep raised £35m ($45.3m) on Monday in an initial public offering that gave an exit to media company Channel 4, Business Insider has reported. Eve Sleep supplies high-grade foam mattresses, pillows, duvets and sheets through an online platform. It generated about £12m of revenue in 2016, up from £2.6m the year… Continue reading Eve Sleep rests easy after $45m IPO
Symphony finds harmony with $63m
BNP Paribas has become the latest financial services firm to back messaging platform Symphony, leading a $63m round that took its total funding to about $230m.
Maris opens Section 32 with $150m
GV founder Bill Maris has formally announced the closure of his venture capital fund, having expanded its size from $100m to $150m because of strong investor interest.
DMG dives into corporate venturing
Entertainment producer DMG Entertainment has formed a $300m investment unit called DMG Capital that will operate across the visual entertainment spectrum.
Cardior shows heart in $16.5m series A
Boehringer Ingelheim and Bristol-Myers Squibb have backed a series A round for Cardior Pharmaceuticals, a heart failure-focused spinout of Hannover Medical School.